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Abstract 1 
The emerging pathogenic multidrug-resistant yeast Candida auris is an 2 
important source of healthcare–associated infections and of growing global 3 
clinical concern. The ability of this organism to survive on surfaces and 4 
withstand environmental stressors creates a challenge for eradicating it from 5 
hospitals. A panel of C. auris clinical isolates was evaluated on different 6 
surface environments against the standard disinfectant sodium hypochlorite 7 
and high level disinfectant peracetic acid. C. auris was shown to selectively 8 
tolerate clinically relevant concentrations of sodium hypochlorite and peracetic 9 
acid in a surface dependent manner, which may explain its ability to 10 
successfully persist within the hospital environment.  11 
 12 
 13 
  14 
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Introduction 1 
Worldwide, fungal infections affect more than a billion people, resulting in 2 
approximately 11·5 million life-threatening infections and more than 1.5 million 3 
deaths annually. There have been significant strides made in tackling these 4 
infections over the past decade, but the global impact of these measures has 5 
yet to be realized [1]. An important fungus worth consideration in this context is 6 
the multidrug-resistant yeast Candida auris, which has been increasingly 7 
described as a major global concern and cause of major nosocomial outbreaks 8 
[2]. The implications for infection control are significant. Understanding the 9 
mechanisms of spread and survival of this pathogen in the hospital 10 
environment is therefore crucial, particularly as it is able to persist on plastics 11 
and steel, and survive as biofilms [3, 4]. Several recent investigations have 12 
confirmed that C. auris is capable of prolonged survival on surfaces [4, 5], and 13 
have shown that surface disinfection protocols have variable and 14 
unsatisfactory outcomes [5]. Given that it has been shown recently that 1000 15 
ppm of an active chlorine solution is highly effective against these organisms 16 
when tested in suspension [6] the interaction between the pathogen and 17 
surfaces is likely to be important in determining survival of C. auris in the 18 
hospital environment. Our own work confirms this, with C. auris biofilms being 19 
generally insensitive to a range of key antimicrobial agents, thus prolonging 20 
their survival capacity [3]. The purpose of this study was to investigate the 21 
general disinfectant sodium hypochlorite (NaOCl), commonly used for terminal 22 
cleaning within the hospital environment, and the high level disinfection agent 23 
peracetic acid (PA), on different substrate surfaces. These data will support 24 
our understanding of how C. auris responds to different levels of challenge on 25 
surfaces representative of the hospital environment. 26 
 27 
Material and Methods 28 
Strains and culture conditions 29 
Four Candida auris (Ca) isolates obtained from various clinical sites [7], (NCPF 30 
8971, NCPF 8973, NCPF 8977, NCPF 8978) were used, as previously 31 
described [3]. All isolates were identified by ribosomal DNA (rDNA) gene 32 
sequencing or matrix-assisted laser desorption ionization–time of flight 33 
(MALDI-TOF) [7]. Candida glabrata (Cg) ATCC 2001 and Candida albicans 34 
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(Ca) ATCC 10231 were used as reference strains. All strains were stored and 1 
maintained on Sabouraud dextrose (SAB) agar (Oxoid, Hampshire, UK) prior 2 
to propagation in yeast peptone dextrose (YPD) (Sigma-Aldrich, Dorset, UK) 3 
medium overnight at 30°C. Cells were prepared accor ding to a modified 4 
version of the British Standards for chemical disinfectants and antiseptics [8]. 5 
Briefly, cells were washed by centrifugation in phosphate buffered saline 6 
([PBS] Sigma-Aldrich, Dorset, UK), and standardised to 1 x 107 cells/mL in 7 
sterile water containing 5% foetal bovine serum to simulate organic material.  8 
 9 
Surface disinfection testing 10 
The following test surface substrates were used: cellulose matrix (IPS 11 
Converters, Oldham, UK [1.25cm2]), 304 stainless steel (LaserMaster, 12 
Redruth, UK [3.14cm2]) and Thermanox™ polyester coverslips (Fisher 13 
Scientific, Loughborough, UK [1.32cm2]). Following the adhesion phase, non-14 
adherent cells were removed by washing with 1 mL PBS.  Next, each surface 15 
was challenged with NaOCl 1000 ppm or 10000 ppm, (Fisher Scientific, 16 
Loughborough, UK) or PA 2000 ppm (Acros Organics, Geel, Belgium). Both 17 
agents were diluted to their working concentrations in sterile water. Following 5 18 
min or 10 min exposure, disinfectants were neutralized with 5% sodium 19 
thiosulphate (Fisher Scientific, Loughborough, UK) for 15 min. The neutralizer 20 
alone did not have a detrimental impact on Candida viability when treated in 21 
the absence of a disinfectant (data not shown). Substrate sections were then 22 
sonicated at 35 kHz for 10 min in sterile H2O to remove cells, and serial ten-23 
fold dilutions in sterile water were plated on to SAB agar according to the Miles 24 
and Misra plate count method; plates were incubated at 30°C for 48 h. Parallel 25 
experiments were also performed to assess the potential for regrowth following 26 
disinfection procedures. After treatment and neutralization as described above, 27 
test coupons were replaced in 10mL of fresh YPD media and incubated for 24 28 
h at 30°C with gentle rotation at 100 rpm. Substrat e adhered C. auris cells 29 
treated with sterile water acted as a positive control, with substrates containing 30 
no C. auris cells included as negative controls throughout this study. After 24 31 
h, the optical density readings were measured at a wavelength of 530nm 32 
(OD530) using a microtitre plate reader (FluoStar Omega, BMG Labtech, 33 
Aylesbury, UK).  34 
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 1 
Statistical analysis 2 
Data distribution, statistical analysis and graph production was performed 3 
using GraphPad Prism (version 7; La Jolla, CA, USA). Student t-tests were 4 
used to compare treated and untreated samples. A one-way analysis of 5 
variance and post-hoc Tukey test was used to compare the effectiveness of 6 
each disinfectant against the 3 different substrates. All experiments were 7 
performed in triplicate on three independent substrates, with the mean of each 8 
experiment used for analyses. Statistical significance was achieved if p<0.05. 9 
 10 
Results  11 
Initially, a standard disinfectant challenge was performed against C. auris on 12 
different substrates relevant to the hospital environment. A cellulose substrate 13 
was included to act as control for porosity. All four C. auris were significantly 14 
killed by NaOCl challenge at 1000 and 10000 ppm, irrespective of substrate 15 
and strain, though differences were observed between these substrates. 16 
Complete eradication (100%) was only achieved on the cellulose substrate 17 
(Fig 1A). On the non-porous materials, significant quantities of viable yeast 18 
cells were killed on the steel surface following NaOCl at all treatment 19 
parameters, with an approximate 2.5 log10 reduction (p<0.001), with no 20 
significant differences observed at each time point and concentration tested 21 
(Fig 1B). Notably, those isolates treated with 1000 ppm for 5 min showed 22 
significantly more regrowth compared to the other test conditions (p<0.001). 23 
When C. auris was tested on a polymer substrate 5 min exposure at 1000ppm 24 
was the least effective overall; although there was significant activity observed 25 
(mean log10 reduction = 1.29; p<0.001), 4.95 log10 was retained on the surface 26 
(Fig 1C). However, following an increased contact time of 10 min, or increased 27 
concentration to 10000 ppm, significantly enhanced activity was observed 28 
(p<0.001), with an approximate overall 3.5 log10 reduction. When comparing 29 
both increased treatment parameters, no significant differences were observed 30 
between the regimens (P=0.347), and no notable regrowth was detected. 31 
 32 
Following a standard disinfection challenge, the efficacy of the HDL agent PA 33 
was assessed. When tested against 2000 ppm of PA, it was shown that all C. 34 
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auris isolates were significantly killed by this agent. However, differences were 1 
again detected between substrates. As observed with NaOCl, complete 2 
eradication (100%) was achieved on the cellulose matrix (Fig 2A), with this 3 
same fungicidal activity also observed on the polymer substrate (Fig 2B). 4 
However, compared to the other two substrates, significant quantities of viable 5 
cells were recovered from the steel substrate following PA challenge (mean 6 
log10 = 3.19; p<0.001), with an overall 2.70 log10 reduction (p<0.001) (Fig 2C). 7 
When re-inoculated into media post-challenge, substantial regrowth was 8 
recorded from both steel and polymer substrates, with minimal quantities 9 
recovered from the cellulose substrate. 10 
 11 
For both disinfectants on each of the substrates, no differences were observed 12 
between strains, and both exhibited a similar profile to C. glabrata and C. 13 
albicans. Similarly, the presence of BSA was shown to have no effect of any 14 
treatments compared to no BSA controls. Liquid suspension tests showed that 15 
NaOCl and PA were highly effective at <20ppm and 40ppm, respectively. 16 
 17 
Discussion 18 
Although the precise mechanism of C. auris nosocomial transmission remains 19 
unknown, it is thought to be a multi-factorial process that involves colonization 20 
of the healthcare environment and equipment. C. auris has been reported to 21 
tolerate a number of environmental stressors, including temperature and salt, 22 
and some strains appear to have different phenotypes; all of these factors may 23 
have a role in persistence within the environment and the host [7]. We 24 
therefore set out to investigate how resilient C. auris is within a controlled 25 
disinfection challenge using clinical isolates from the UK [7]. Here we report for 26 
the first time that both standard and high-level disinfection strategies were 27 
unable to completely eradicate C. auris from non-porous substrates.  28 
 29 
Chlorine based disinfectants have variable yeasticidal activity against 30 
planktonic C. auris [6, 9], though their role in surface disinfection procedures 31 
lacks definitive evidence. Recently, it has been shown that quaternary 32 
ammonium compounds were poorly active against C. auris, whereas 33 
Environmental Protection Agency registered hospital disinfectants, such as 34 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 7
NaOCl containing solutions, were fungicidal on surfaces [5]. In a recent UK 1 
outbreak, Schelenz and colleagues implemented chlorine based disinfectants 2 
at 1000ppm three times daily for environmental cleaning, and 10000ppm for 3 
terminal cleaning [2]. The data presented herein support this approach, 4 
although we showed that length of exposure at 1000ppm is an important 5 
consideration. 6 
 7 
It was interesting that we observed a significant difference in activity between 8 
polymer and steel, which could be explained by the general ability of Candida 9 
species to adhere and form biofilms that are inherently more resistant. 10 
Whereas the isolates on steel responded by approximately 3 log10 equally to 11 
the treatments regimens, on plastic we demonstrated differential activity 12 
depending on concentration and time of exposure to NaOCl. Another study 13 
reported greater efficacy of chlorine based products on steel [5], but 14 
differences in experimental design may explain this, e.g. products and 15 
inoculum. Taken together, these data suggest the standard disinfection 16 
procedures are surface dependent, and given the diversity of fomites in the 17 
hospital setting then this could pose a problem for disinfection. To this end we 18 
decided to explore a representative high-level disinfection protocol. Here PA 19 
was used, a disinfectant routinely used for endoscope reprocessing. It was 20 
shown that on plastic polymers this disinfectant challenge was more effective, 21 
showing significant reduction compared to stainless steel. To our knowledge, 22 
ours is the first report to investigate this agent. Although PA may offer a 23 
superior disinfectant strategy our data suggest that there may still be a risk of 24 
transmission of C. auris via contaminated endoscopes. C. auris has been 25 
isolated from a number of clinical sources [7], so it is reasonable to suggest 26 
that this and other hospital instruments could facilitate transmission.   27 
 28 
Recent studies have suggested that C. auris has been shown to survive on 29 
steel and plastic surfaces for 1 and 4 weeks, respectively [4, 10]. Comparison 30 
of C. auris to C. parapsilosis persistence on plastics was quantified under 31 
controlled hospital conditions (temperature and humidity). Low density test 32 
suspensions (104) of C. auris were shown to remain viable (CFU counts) for up 33 
to 14 days, though more sensitive esterase measurements suggested viable 34 
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activity up to 28 days that was comparable to C. parapsilosis [4]. Piedrahita 1 
and colleagues further investigated C. auris in comparison to C. albicans, C. 2 
glabrata and C. parapsilosis, specifically looking at moist and dry inocula over 3 
7 days. Here they demonstrated that in moist conditions all species were 4 
recovered in near maximum efficiency after 7 days. By comparison, only 40% 5 
of the dried inoculum of C. auris was recovered on the steel substrate; 6 
although this was a significantly higher recovery than with C. albicans, C. 7 
glabrata and C. parapsilosis recovery rates were higher still at approximately 8 
65% [10]. This is in line with our own findings, showing comparable disinfectant 9 
sensitivity profiles for both C. auris and C. glabrata. Nevertheless, given the 10 
multi-drug resistance phenotype of C. auris compared to other species its 11 
ability to persist is of concern.  12 
 13 
While this study provides a useful insight into potential complications with 14 
disinfectant procedures, there are some limitations. We only tested a limited 15 
panel of C. auris strains on a limited number of surfaces, although they did 16 
demonstrate similar sensitivity profiles across each tested parameter. Future 17 
studies should aim to undertake extensive analysis with commercial products 18 
in conjunction with up-to-date infection control guidelines. 19 
 20 
In conclusion, this study reveals the potential challenges we face in controlling 21 
this emerging fungal pathogen in healthcare environments. Only with a greater 22 
understanding of the biology of this multi-resistant pathogen will we be able to 23 
identify the optimal control interventions.    24 
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Figure 1. Efficacy of sodium hypochlorite on Candida auris, Candida glabrata 1 
and Candida albicans on three different substrates. 2 
  3 
Cellulose matrix (A), stainless steel (B) and polymer (C) were inoculated with 1 4 
x 107 cells/mL of C. auris (NCPF), C. glabrata (CG) and C. albicans (CA) for 90 5 
min before being treated with 1000ppm NaOCl for 5 min, 1000ppm for 10 min 6 
and 10000ppm for 5 min. Viable cells were then quantified by CFU (left hand y-7 
axis) and regrowth was measured spectrophotometrically (right hand y-axis). 8 
Data represents means ± standard deviation of triplicate datasets, with CFU 9 
log10 reduction of each test substrate normalised to 1cm2.  # indicates 10 
complete eradication compared to untreated control. N.A. = not applicable. 11 
 12 
 13 
Figure 2. Efficacy of PA on Candida auris, Candida glabrata and Candida 14 
albicans on three different substrates. 15 
  16 
Cellulose matrix (A), stainless steel (B) and polymer (C) were inoculated with 1 17 
x 107 cells/mL of C. auris (NCPF), C. glabrata (CG) and C. albicans (CA) for 90 18 
min before being treated with 2000ppm PA for 5 min. Cell viability (left hand y-19 
axis) and re-growth (right hand y-axis) were quantified by CFU and 20 
spectrophotometric readings, respectively. Data represents means ± standard 21 
deviation of triplicate datasets, with CFU log10 reduction of each test substrate 22 
normalised to 1cm2. # indicates complete eradication compared to untreated 23 
control.  24 
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